COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapies.

Chi X, Lin R, Yuan Y

Open source

DOI
10.1093/biomtc/ujaf077
Published
2025 Apr 2
Container
Biometrics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/biomtc/ujaf077,
  title = {COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapies.},
  author = {Chi X and Lin R and Yuan Y},
  year = {2025},
  journal = {Biometrics},
  doi = {10.1093/biomtc/ujaf077},
  url = {https://doi.org/10.1093/biomtc/ujaf077}
}

RIS

TY  - JOUR
TI  - COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapies.
AU  - Chi X
AU  - Lin R
AU  - Yuan Y
PY  - 2025
JO  - Biometrics
DO  - 10.1093/biomtc/ujaf077
UR  - https://doi.org/10.1093/biomtc/ujaf077
ER  - 

APA

X, C., R, L., & Y, Y. (2025). COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapies.. Biometrics. https://doi.org/10.1093/biomtc/ujaf077

Source records